Breaking News

Evonik, Lilly Renew Long-term API Supply Pact

Evonik to provide APIs and intermediates for use in key Lilly products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik Industries and Eli Lilly and Co. have renewed a long-term supply agreement for active pharmaceutical ingredients (APIs) and intermediates for use in key Lilly human and veterinary drug products. Evonik acquired Lilly’s Tippecanoe site in Lafayette, IN, in January 2010. Since then, the facility has been operating as a contract development and manufacturing organization (CDMO) for the pharma industry, serving more than 20 Evonik customers. The facility has 170 cubic meters of High Potenc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters